Best treatments for multiple sclerosis (MS)
17 products may treat multiple sclerosis (also known as MS), spanning FDA drug classes such as purine antimetabolite, adrenocorticotropic hormone, potassium channel blocker. The current highest-rated option is mavenclad. Ranked below by our independent recall-safety rating (rated where FDA data exists) — not medical advice; always consult a professional.
Quick answer: Of the 17 drugs we list for multiple sclerosis, 6 are available as lower-cost generics, spanning classes such as purine antimetabolite, adrenocorticotropic hormone, potassium channel blocker. They’re ranked by each drug’s FDA recall-safety record — not clinical effectiveness for multiple sclerosis — so confirm the right choice with your prescriber.
Understanding multiple sclerosis
Multiple sclerosis (MS) is a disease of the central nervous system — the brain and spinal cord — thought to be an autoimmune condition in which the immune system mistakenly attacks myelin, the protective sheath around nerve fibers. This damage slows or blocks the signals traveling between the brain and the body. MS is most commonly diagnosed between ages 20 and 40 and affects women more often than men, though it can occur at any age. Symptoms vary widely and may include vision problems, muscle weakness, numbness or "pins and needles," trouble with balance and coordination, fatigue, and difficulties with thinking or memory. Many people have a relapsing course, in which symptoms flare and are then followed by remissions with reduced or no symptoms. There is no single specific test for MS; doctors use medical history, a neurological exam, MRI scans, and other tests to look for signs of nerve damage in different areas and at different times. There is no cure, but treatments can slow the disease and help control symptoms. Care is individualized and often combines medication with physical or occupational therapy. This is general information, not medical advice.
First-line treatment
For people with relapsing forms of MS, the standard approach is to start a disease-modifying therapy (DMT). The American Academy of Neurology's 2018 practice guideline (reaffirmed October 2024) found that several DMTs reduce the rate and risk of MS relapses and of new or enlarging lesions on MRI, and it takes a personalized approach — weighing each therapy's benefits and risks for the individual patient. Sudden flare-ups (relapses) are often treated separately with steroids (corticosteroids) to reduce inflammation and help nerves work better; steroids are more effective for the relapsing-remitting form. Additional medicines and rehabilitation address specific symptoms such as muscle spasms, bladder problems, fatigue, or mood. Because everyone's needs differ and the right treatment often changes over time, a clinician should guide and adjust the plan. This is general information, not medical advice.
Top-rated picks for multiple sclerosis: 1. Mavenclad · 2. Ocrevus · 3. Purified Cortrophin Gel
| # | Drug | Rating | Type | Form | Class | Generic? | Pharmacy pays | |
|---|---|---|---|---|---|---|---|---|
| 1 | 70/100 | Prescription | Tablet | Purine Antimetabolite | No data | — | View → | |
| 2 | 70/100 | Prescription | Injectable | — | No data | — | View → | |
| 3 | 70/100 | Prescription | Injectable | Adrenocorticotropic Hormone | No data | — | View → | |
| 4 | 68/100 | Prescription | Kit | — | No data | — | View → | |
| 5 | 68/100 | Prescription | Injectable | — | No data | — | View → | |
| 6 | Not yet rated | Prescription | Injectable | Adrenocorticotropic Hormone | No data | — | View → | |
| 7 | Not yet rated | Prescription | Tablet | Potassium Channel Blocker | Generic | $12 | View → | |
| 8 | Not yet rated | Prescription | Kit | Interferon beta | No data | — | View → | |
| 9 | Not yet rated | Prescription | Tablet | Potassium Channel Blocker | Generic | $12 | View → | |
| 10 | Not yet rated | Prescription | Capsule | Skeletal Muscle Relaxant | Generic | $14 | View → |
Narrow by drug class
Explore the class hubs: adrenocorticotropic hormone · gamma-aminobutyric acid-ergic agonist · interferon beta · potassium channel blocker
Full ranking · 17 treatments
mavenclad
Boxed warningPrescriptionFDA-sourced
Mavenclad (Cladribine) is a purine antimetabolite used to treat Hairy Cell Leukemia, Non-Hodgkin Lymphoma, Multiple Sclerosis, B-Cell Chronic Lymphocytic Leukemia.
Price varies
ocrevus
PrescriptionFDA-sourced
Ocrevus (Ocrelizumab) is a medication used to treat Multiple Sclerosis.
Price varies
purified cortrophin gel
PrescriptionFDA-sourced
Purified Cortrophin Gel (Corticotropin) is an adrenocorticotropic hormone used to treat Collagen Diseases, Erythema Multiforme, Multiple Sclerosis, Nephrotic Syndrome.
Price varies
betaseron
PrescriptionFDA-sourced
Betaseron (Interferon Beta-1b) is a medication used to treat Multiple Sclerosis, Brain Neoplasms, Renal Cell Carcinoma, Cryoglobulinemia.
Price varies
tyruko
Boxed warningPrescriptionFDA-sourced
Tyruko (Natalizumab-Sztn) is a medication used to treat Crohn Disease, Multiple Sclerosis.
Price varies
acthar gel
PrescriptionFDA-sourced
Acthar Gel (Corticotropin) is an adrenocorticotropic hormone used to treat Collagen Diseases, Erythema Multiforme, Multiple Sclerosis, Nephrotic Syndrome.
Price varies
Frequently asked
- What is the best medication for MS?
- MS is multiple sclerosis. There isn't a single "best" medication for everyone — For people with relapsing forms of MS, the standard approach is to start a disease-modifying therapy (DMT). The American Academy of Neurology's 2018 practice guideline (reaffirmed October 2024) found that several DMTs reduce the rate and risk of MS relapses and of new or enlarging lesions on MRI, and it takes a personalized approach — weighing each therapy's benefits and risks for the individual patient. Sudden flare-ups (relapses) are often treated separately with steroids (corticosteroids) to reduce inflammation and help nerves work better; steroids are more effective for the relapsing-remitting form. Additional medicines and rehabilitation address specific symptoms such as muscle spasms, bladder problems, fatigue, or mood. Because everyone's needs differ and the right treatment often changes over time, a clinician should guide and adjust the plan. This is general information, not medical advice.. Compare every option ranked above by our independent recall-safety rating (not an efficacy measure); this is general information, not medical advice.
- What treats multiple sclerosis?
- Our catalog lists 17 products that may treat multiple sclerosis, based on NIH RxClass (MED-RT “may treat”) drug-classification data — not the verbatim FDA label. They're rated where FDA recall-safety data exists; the current top-rated option is mavenclad.
- What is the best-rated treatment for multiple sclerosis?
- By our independent recall-safety rating — not an efficacy measure — mavenclad ranks highest among the products we list for multiple sclerosis. Always consult a professional.
- How are these treatments ranked?
- By our independent score, currently based on FDA regulatory recall-safety data (the methodology blends additional sources as they come online). See the How we rate page.
- What types of drugs treat multiple sclerosis?
- Treatments for multiple sclerosis span FDA drug classes including purine antimetabolite, adrenocorticotropic hormone, potassium channel blocker, interferon beta, skeletal muscle relaxant. Compare every option side by side, ranked by independent rating, above.
Treatment associations are derived from NIH RxClass (MED-RT “may treat”) drug-classification data — not the verbatim FDA label. This is general reference, not medical advice — always consult a licensed professional.
Sources
The clinical overview above is written from these authoritative public-health and medical-society sources, independently reviewed against each.
- Multiple Sclerosis (MedlinePlus, U.S. National Library of Medicine) ↗
- Multiple sclerosis — Medical Encyclopedia (MedlinePlus, U.S. National Library of Medicine) ↗
- Multiple sclerosis: Treatment (UK NHS) ↗
- Practice Guideline Recommendations: Disease-modifying Therapies for Adults with Multiple Sclerosis (American Academy of Neurology; reaffirmed October 19, 2024) ↗
- AAN publishes guideline on disease-modifying therapies for MS (Consortium of Multiple Sclerosis Centers, summarizing the AAN 2018 guideline) ↗